Natural epigallocatechin-3-gallocarboxylate nanoformulation loaded doxorubicin to construct a novel and low cardiotoxicity chemotherapeutic drug for high-efficiency breast cancer therapy.

J Nanobiotechnology · 2024 · PMC11667857 · PMID 39719646

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

an increasing trendno p-value reported

In contrast, the plasma concentration of the EGCG&Cys(DOX) group also showed a decreasing trend after administration but an increasing trend during the 15–20 min and 45–60 min periods.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.